Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. SELLAS Life Sciences Group
SLS

Buy SLS Stock

SLS
See SLS stock price and Buy/Sell SELLAS Life Sciences Group with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Market Cap
$43.16M
1 Year High
$9.92
Volume
26.43k
1 Year Low
$2.02
Price to Earnings Ratio
Open
$2.13
Dividend Rate
High
$2.22
Dividend Yield
Low
$2.13

Community

People who own or watch SLS stock

SLS Price Targets

What analysts think SLS stock price will be.
$2.19
$8.67
295.9% Upside
$1$11

SLS Stock Rating

What analysts recommend for SLS stock, on a scale from 1(buy) to 5(sell).
Strong Buy1 / 5
BuyHoldSell

SLS Stock Earnings

The value each SLS share was expected to gain vs. the value that each SLS share actually gained.
Expected
Actual

SLS Stock News

Frequently Asked Questions (FAQ)

As of Sep 26, 2022, the market cap for SLS stock is $43.16M

The 52-week high for SLS stock is $9.92. The current SLS stock price $2.19 is 77.92% below its 52-week high

The 52-week low for SLS stock is $2.02. The current SLS stock price $2.19 has increased 7.76% from its 52-week low

No, the SLS stock does not pay dividends to its shareholders

The target price for SLS stock is $8.67 based on the average of what a group of analyst think SLS stock could be worth at a future date. This is not a prediction by Public.com

Buy SLS Stock

SLS
See SLS stock price and Buy/Sell SELLAS Life Sciences Group with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch SLS stock
  • automata avatar
  • Bwalt10 avatar
  • raspopoj avatar
  • normanj avatar
  • franniea81 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.